Related references
Note: Only part of the references are listed.Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains
Carlos Juan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Diversity, Epidemiology, and Genetics of Class D beta-Lactamases
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Nationwide Investigation of Extended-Spectrum β-Lactamases, Metallo-β-Lactamases, and Extended-Spectrum Oxacillinases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Strains in France
Didier Hocquet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
V. Miriagou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa
Damien Fournier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital
P. Cholley et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Hospital outbreak of Pseudomonas aeruginosa producing extended-spectrum oxacillinase OXA-19
Pascal Cholley et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Detection of the Novel Extended-Spectrum β-Lactamase OXA-161 from a Plasmid-Located Integron in Pseudomonas aeruginosa Clinical Isolates from Spain
C. Juan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Bartolome Moya et al.
PLOS PATHOGENS (2009)
Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia
S. Kalai Blagui et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Susceptibility of Pseudomonas aeruginosa to antimicrobials:: a 2004 French multicentre hospital study
J. D. Cavallo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa
Xiaofei Jiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa
D Hocquet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Genetic analysis of a multiresistant strain of Pseudomonas aeruginosa producing PER-1 β-lactamase
C Llanes et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
BEL-1, a novel clavulanic acid-inhibited extended-spectrum β-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Functional and structural characterization of the genetic environment of an extended-spectrum β-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India
D Aubert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa:: Novel developments and clinical impact
GF Weldhagen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 β-lactamase from Pseudomonas aeruginosa
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
DM Livermore
CLINICAL INFECTIOUS DISEASES (2002)
Molecular characterization of a novel class 1 integron containing blaGES-1 and a fused product of aac(3)-ib/Aac(6 ')-Ib ' gene cassettes in Pseudomonas aeruginosa
W Dubois et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat
PA Bradford
CLINICAL MICROBIOLOGY REVIEWS (2001)
OXA-28, an extended-spectrum variant of OXA-10 β-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
